Dr. Ana I. Robles

National Cancer Institute, NIH

Droplet Digital PCR Aids Prognostic Stratification of Lung Cancer Patients

Dr. Ana Robles, National Cancer Institute, NIH, explains how her team used formalin-fixed paraffin embedded samples, routinely collected from lung cancer patients, to determine the staging of lung cancers using droplet digital PCR. She goes on to share how developing biomarkers for lung cancer progression can help clinical management of patients after surgery.

LIKE 0


Dr. Ana I. Robles
PCR

Dr. Ana I. Robles

Biography

Dr. Ana I. Robles studies... More

Dr. Ana I. Robles

National Cancer Institute, NIH

Dr. Ana I. Robles studies lung cancer biomarkers, cancer susceptibility syndromes and senescence, the effect of genetic variation on microRNA-mediated pathways as well as the identification of lung cancer progenitor cells.